Revenue: The sum of all revenue fields included for a company's operating activities.
Larimar Therapeutics, Inc. (LRMR) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-80.60M |
|
-- |
|
-- |
|
$90.89M |
|
$-90.89M |
|
$10.29M |
|
$-80.60M |
|
$-80.60M |
|
$-80.60M |
|
$-80.60M |
|
$-80.60M |
|
$-80.60M |
|
$-90.89M |
|
$-95.83M |
|
61.26M |
|
61.26M |
|
$-1.32 |
|
$-1.32 |
|
| Balance Sheet Financials | |
$195.30M |
|
$0.88M |
|
$4.92M |
|
$200.22M |
|
$24.36M |
|
-- |
|
$4.06M |
|
$28.41M |
|
$171.81M |
|
$171.81M |
|
$171.81M |
|
63.82M |
|
| Cash Flow Statement Financials | |
$-70.76M |
|
$-85.39M |
|
$161.88M |
|
$28.09M |
|
$33.82M |
|
$5.74M |
|
$8.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-71.28M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-46.91% |
|
-46.91% |
|
-40.26% |
|
-46.91% |
|
$2.69 |
|
$-1.16 |
|
$-1.16 |
|